The efficacy of semaglutide as a weight loss treatment option has been demonstrated in several clinical trials, including the SUSTAIN (Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes) and PIONEER (Peptide Innovation for Early Diabetes Treatment) trials for type 2 diabetes, as well as the STEP (Semaglutide Treatment Effect in People with Obesity) trials, which specifically focused on weight loss
The schedule above reflects how oral semaglutide treatment is typically introduced and managed
JPTs Diabetes Peptide%3b GLP-1 receptor agonists Glucagon-like Peptide 1 (GLP-1) and other GLP-1 receptor agonists have proven to be an effective treatment of Type 2 diabetes and obesity, offering significant benefits
Enteric-coated peppermint oil capsules are even more effective for lower GI bloating because they bypass the stomach and release in the intestines where they are most needed
But when gastric emptying slows too much, especially during the early dose escalation phase, the stomach essentially holds food longer than the body expects
This article dives into how semaglutide may affect hypothyroidism and its related challenges